Seres Therapeutics (MCRB) Receivables (2016 - 2026)
Seres Therapeutics (MCRB) posted Receivables of $233000.0 for Q1 2026, up 48.41% sequentially from $157000.0 in Q4 2025, and down 97.42% YoY from $9.0 million in Q1 2025.
Seres Therapeutics (MCRB) Receivables (2016 - 2026) Analysis & Trends
Seres Therapeutics has reported Receivables for 9 years, with the latest figure at $233000.0 in Q1 2026.
- Quarterly Receivables fell 97.42% year-over-year to $233000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $233000.0 (down 97.42% YoY) and the FY2025 annual result came in at $14.9 million, up 132.51% from the prior year.
- Receivables climbed to $233000.0 in Q1 2026 per MCRB's latest filing, from $157000.0 in the prior quarter.
- Over five years, Receivables peaked at $9.0 million in Q1 2025 and troughed at $157000.0 in Q4 2025.
- A 3-year average of $3.2 million and a median of $404000.0 in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2025 and 2026: Receivables slumped 97.55% in 2025, then tumbled 97.42% in 2026.
- Over 3 years, Receivables stood at $6.4 million in 2024, then plunged by 97.55% to $157000.0 in 2025, then jumped by 48.41% to $233000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $233000.0, $157000.0, and $404000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Seres Therapeutics | 44.36 Mn | 44.36 Mn | - | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274,000.00 |
| Mar 31, 2026 | 233,000.00 |
| Dec 31, 2025 | 157,000.00 |
| Sep 30, 2025 | 404,000.00 |
| Mar 31, 2025 | 9.03 Mn |
| Dec 31, 2024 | 6.41 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Mar 31, 2021 | 2.60 Mn |
| Dec 31, 2020 | 17.59 Mn |
| Sep 30, 2020 | 3.39 Mn |
| Jun 30, 2020 | 2.93 Mn |
| Mar 31, 2020 | 2.08 Mn |
| Dec 31, 2019 | 1.79 Mn |
| Sep 30, 2019 | 1.72 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Mar 31, 2019 | 6.67 Mn |
| Jun 30, 2018 | 350,000.00 |
| Mar 31, 2018 | 350,000.00 |
| Dec 31, 2017 | 1.02 Mn |